InFocus Capital Partners
Jericho, New Yorkinfocuscapitalpartners.com
Overview
InFocus Capital Partners specializes in the identification, capitalization and development of breakthrough and disruptive opportunities in life sciences with an ophthalmic focus. The Fund's experience, partnership structure and coverage of ophthalmic innovations yield a differentiated investment opportunity – optimizing the probability for successful returns.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Re-Vana Therapeutics | Nov 2022 | Series A | Co-investor |
| Stuart Therapeutics, Inc. | Mar 2021 | Series A | Lead |
| ONL Therapeutics | Dec 2020 | Series B | Co-investor |
| Re-Vana Therapeutics | Jun 2020 | Pre Seed | Co-investor |
| Mojo Vision | Apr 2020 | Series B Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
